Lv52
910 积分 2024-02-27 加入
Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
6个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
6个月前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
6个月前
已完结
Tirzepatide for Obesity Treatment and Diabetes Prevention
6个月前
已完结
皖公网安备34019202002308
